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Purpose/Objective: To compare the quality of 3D versus 2D planning 
in postmastectomy patients in terms of target volume coverage and 
sparing of organs at risk. 
Materials and Methods: 27 postmastectomy patients, 16 with left and 
11 with right sided breast cancer. Clinical target volume was chest 
wall and supraclavicular fossa ± axilla. PTV1a consisted of chest wall, 
up to skin surface and PTV1b consisted of supraclavicular fossa ± axilla 
plus 1 cm margin; distance from skin surface was 0,5 cm. Deliniated 
organs at risk were both lungs, spinal cord and heart for left sided 
breast cancer. Total dose was 50 Gy in 25 fractions. For each patient 
2 plans were made: 3D and 2D plan. For 3D plan forward IMRT 
planning technique was used. Tangential fields were used for PTV1a 
and AP-PA opposed fields for PTV1b, all with 6MV photons. 2D plan 
was made using direct electron field (energy 9-12 MeV, depending on 
chest wallthickness) on PTV1a and combination of direct electron field 
(18 Mev) and direct photon field (6 MV) on PTV1b. For PTV1a bolus of 
0,5 cm was used. For 3D plans required PTV coverage with 95-107% of 
prescribed dose was at least 85%. Dose constraints for OAR were 
V20Gy< 35% for lung, Dmax <45 Gy for spinal cord and V20Gy< 10% and 
V40Gy< 5% for heart. Patients were placed on Med-Tec MT-350 with 
both hands above head, head in forward position. For planning XIO 
4.3.1 and 4.6.4 with fast-superposition and superposition algorhytm 
respectably for the photon beam calculation were used. Electron 
fields were calculated with pencil beam algorhytm. The CT slice 
thickness and calculation resolution of 0,2 cm was used. 
Statistical method: student t-test. 
Results 
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Left 
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3D 88.8 
(3.5)* 
90.4 
(3.9) 
53.5 
(0.2) 
31.9 
(6.3) 
16.2 
(2.7) 
0.35 
(0.88) 
0.67 
(0.49)
7.6 
(1.9) 
3.5 
(1.1) 
5.0 
(1.2) 
36. 
(9.6) 
2D 83.1 
(7.2) 
61.2 
(16.2) 
73.5 
(3.3) 
31.0 
(13.3) 
15.2 
(5.4) 
0.85 
(1.39) 
1.98 
(0.98)
5.3 
(3.5) 
0.4 
(0.5) 
5.6 
(1.9) 
33.2 
(6.2) 
p-
value 
<0.01 <10-6 <10-
6 
NS** NS NS <10-4 <0.03 <10-6 NS NS 
Right 
sided 
 
3D 91.2 
(3.2) 
89.5 
(2.0) 
53.6 
(0.2) 
0.06 
(0.1) 
0.4 
(0.1) 
34.2 
(2.0) 
17.0 
(1.3) 
 39.7 
(5.8) 
2D 82.4 
(6.4) 
51.7 
(19.3) 
74.4 
(2.2) 
0.25 
(0.4) 
2.2 
(0.8) 
28.6 
(9.6) 
14.8 
(4.2) 
34.1 
(4.6) 
p-
value 
<0.01 <10-5 <10-
6 
<10-6 NS NS NS <0,03 
 
* median and standard deviation, ** not significant 
Statistically significant difference for left-sided breast cancer was 
observed in PTV1a and PTV1b coverage, MD on right lung, V20Gy and 
V40Gy on heart and Dmax. For right-sided breast cancer statistically 
significant difference was observed in PTV1a and PTV1b coverage, 
V20Gy on left lung, Dmax on spinal cord and Dmax.  
Conclusions: 3D planning provided significantly better PTV coverage 
and lower maximal doses, but without significant influence on doses 
on OAR (lungs and spinal cord) when compared to 2D planning. 
Nevertheless, higher doses on heart were observed with 3D planning, 
but within dose constraints. 
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Purpose/Objective: The aim of this study is to compare the dose 
distributions of intensity-modulated radiotherapy (IMRT) plans and 
accuracy of patient setting between MHI TM-2000 (VERO), 
TomoTherapy HiArt System (TomoTherapy), and conventional linac 
(Clinac 21EX), all of which are installed in our institution. 
Materials and Methods: One patient with locally advanced ethmoid 
sinus cancer (T4aN0M0) treated by IMRT at our institution was 
evaluated in this planning study. The clinical target volume (CTV) was 
defined as gross tumor volume and right side nasal and paranasal 
sinus. The planning targetvolume (PTV) was defined as the CTV + 
three-dimensional margins of 5 mm. IMRT planning was implemented 
for 3 different treatment machines, including VERO,TomoTherapy, 
and Clinac 21EX, so as to achieve the similar optimal dose delivery to 
the target volumes with the same dose constraints for normal tissues. 
IMRT schedule consisted of 70Gy in 35fr. As the method of IMRT, 
segmental multi-leaf collimator (MLC) IMRT with 9 static ports, helical 
IMRT, and dynamic MLC IMRT with 9 static ports (2 non-coplaner ports 
and 7 coplaner ports), were adopted for VERO, TomoTherapy, and 
Clinic 21EX, respectively. As planning software, iPlan ver.4.5.1, 
TomoTherapy Planning Station 4.1.2, and Eclipse ver.10.0 were used 
for VERO, TomoTherapy, and Clinac 21EX, respectively. The dose-
volume parameters described below were calculated in each 
treatment machine: D2, D50 and D95 of the PTV and CTV; D2 of the 
optic nerves, chiasm, and eye balls; average dose of the Brain. As 
Modality of image guidance, Cone beam CT (KvCT), Cone beam CT 
(MvCT), and 2D EPID were used for VERO, TomoTherapy, and Clinac 
21EX, respectively. 
Results: The dose-volume parameters calculated in each treatment 
machine are shown in the table. 
 
  
Conclusions: The target volume coverage and the normal tissue doses 
in patients with locally advanced ethmoid sinus cancer were compared 
between the 3 treatment plans, using VERO, TomoTherapy, and Clinac 
21EX. All plans achieved acceptable dose delivery, but plan of Clinac 
21EX with 2D EPID may not achieve enough accuracy of patient 
setting.  
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Purpose/Objective: The beam attenuation impact on the planed dose 
distribution, due to the immobilization and repositioning systems 
(IRSs) used in radiotherapy, was studied to evaluate the need of IRS 
contouring.  
Materials and Methods: Three IRSs were selected for this study. In 
particular an uni-frame with PMMA support (UFP) (Tema Sinergie) was 
tested for 3DCRT 6 MV treatments, an uni-frame with carbon support 
(UFC) (Civco) was tested for head and neck IMTR 6 MV treatments and 
a Body Fix (BF) (3D Line) was tested for stereobody 6 and 15 MV 
treatments. The beam attenuation, when the beam axis intercepts the 
IRSs, was measured for 6 MV and 15 MV photon beams by ion-chamber 
and simulated by Eclipse (Varian) TPS to assess the TPS accuracy in 
modelling the IRS. Then 10 patients for each IRS were selected and 
two treatment plans were performed for each patient, with and 
without IRS contouring. The two plans were compared using dose 
volume histograms (DVH) and in particular evaluating the average 
dose to target variations. A method of transit in-vivo dosimetry (IVD) 
by EPID was adopted to verify that the IRS contouring was performed 
and gave the expected results in clinical routine. 
Results: The percentage of attenuations measured by ion-chamber for 
6 and 15 MV beams were 8.0% and 4.5% for UFP, 5.0% and 3.5% for UFC 
and 3% and 2% for BF respectively. These data were well reproduced 
by the TPS within ±1%. The mean percentage target dose variations 
obtained comparing the IRS contoured and not countered plans and 
averaged over the ten selected patients were 2.9 %, 1.1 % and 1.3 % 
for UFP, UFC and BF respectively. While the maximum percentage 
target dose variations were 6.5 %, 2.8 % and 2.5 % for UFP, UFC and BF 
respectively. IVD for patients with contoured IRS, performed in 
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aperiod of 6 moths, showed results within the acceptance criteria of 
±5% in dose for all the cases except one for which the UFP contour 
was missed. 
Conclusions: Our study shows that the attenuations of single beams 
that intercept the IRSs are not indicative of the mean dose target 
variations determined over the whole RT plan, but, as expected, the 
impact of the IRS attenuation is patient’s specific. Therefore in our 
radiotherapy centre all the IRSs are contoured and it takes about 20 
minutes per patient. However for those IRSs whose target dose 
variation is less than 2% we are going to explore two possible 
protocols: not contouring the IRSs, and enhancing the acceptance 
criteria of the DVH to 97% of the prescribed dose to 95% of the target 
volume or auto contouring the IRS with the patient’s body accepting 
some contour artefact. 
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Purpose/Objective: Aim of this study is to compare the planning 
performance of two collimators (fixed and dynamic aperture IRIS) 
mounted on the cyberknife system. 
Materials and Methods: Three treatment plans for each petroclival 
meningioma patient (average target volume 13.9cc) were optimized 
for different collimator setups: up to three fixed, free variable 
aperture IRIS (fIRIS) and IRIS apertures constrained to the fixed plan 
ones (cIRIS). The prescription dose was 25 Gy in 5 fractions and the 
reference isodose for each patient was chosen to produced equivalent 
target coverage for the three plans. The comparison among different 
collimator setups was performed in terms of OARs sparing (brain stem, 
cochlea and omolateral acoustic nerve), CI (van’t Riet et al.), total 
MU, treatment time and body volumes receiving 70%, 50%, 30% and 
10% of the prescription dose. 
Results: Plans for all patients had a mean target coverage of 96.1%, 
and the mean prescription isodose was 81%. The three collimator 
setups did not produce significant differences in terms of OARs sparing 
and CI values. Compared to fixed collimators, both IRIS plans showed 
improvements in low dose regions, with a reduction of 4.9% and 6.7% 
for the total volume enclosed respectively by the 30% and 10% of the 
prescription dose isodoses; no relevant differences were appreciated 
when 70% and 50% isodoses were considered. Treatment time was 
reduced by 16.6% when the IRIS collimator setup was used, with a 
minimal difference between free variable aperture and constrained 
IRIS (~2 min less for fIRIS). The fIRIS setup also allowed a reduction of 
the 5.6% and 8.7% of the total MU number, if compared to fixed and 
cIRIS plans respectively. 
Conclusions: The different collimator setups analysed showed 
nonsignificant differences in terms of OARs sparing for radiosurgery 
treatment of petroclival meningiomas. Using the IRIS collimator with 
free variable aperture can reduce the total volume enclosed by 
medium and low dose isodoses. Moreover, it can also reduce 
treatment time and total MU number. Finally, using IRIS constrained 
apertures instead of free ones could be advantageous in terms of 
treatment planning computation time. 
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Purpose/Objective: The aim of this study was to assess the use of 
equivalent uniform doses (EUD) as a treatment plan quality 
parameter; searching for a possible relationship with Dose Volume 
(DV) evaluation criteria and the difficulties encountered in applying 
EUD to clinical practice. A possible solution to these difficulties using 
EUD (D98%) is suggested. 
Materials and Methods: Ten head and neck tumor cases were 
optimized using biologically based intensity-modulated radiation 
therapy (IMRT) optimization for acceptance according to DV criteria 
and then re-optimized for EUD value acceptability. In all plans the 
absorbed dose limits of the critical organs at risk were to be complied 
with. 
Results: Considering that a plan is EUD acceptable when its value is 
within 5% of the prescription one, there is no link between acceptable 
EUD value and V95% ≥ 95%, which is a DV acceptance criteria. However, 
there is a relationship between acceptable EUD value and D98% ≥ 95%. 
Like low absorbed doses has a great impact on EUD, its value can be 
very influenced with the uncertainty in contouring, the voxel size and 
the uncertainty of TPS doses calculation. To address this 
uncertainties, in our center we use a EUD (D98%),which, for 
calculation, eliminates 2% of points with lower absorbed doses. This 
allows using the EUD (D98%) as plans acceptance parameter. In plans 
optimized for EUD evaluation, it has been observed that the TPS 
attempts to compensate for cold or hot spots by increasing or 
decreasing the absorbed dose to the PTV. This can cause two opposite 
undesirable effects that may lead to an unacceptable overdose or low 
coverage of PTVs. 
Conclusions: The main conclusion of this work is that EUD (D98%) may 
be used as a treatment quality parameter, but should always be 
complementary to DV criteria. 
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Purpose/Objective: The purpose of this study is to compare the 
dosimetric characteristics between Acuros XB and model-based 
algorithm for prostate IMRT with implanted fiducial markers. 
Materials and Methods: CT datasets of 12 prostate cancer patients 
with implanted fiducial markers were selected for the study. 
Prostate(PR): GTV, seminal vesicles (SV), CTV: GTV+SV, PTV-PROST, 
PTV-SV, rectum and bladder were delineated. The PTV-PROST was 
created by symmetrically expanding the PR by 0.7 cm in all directions 
except posteriorly,where it was expanded by 0.4 cm. The PTV-SV is 
derived by expanding the SV 0.5cm in all directions. Treatment plans 
were computed for SMLC-IMRT based on 7 fields with 6MV (6 datasets) 
and 10MV (6 datasets) beams using a Varian Clinac iX with a 120-leaf 
MLC. Dose prescription was set to 76.0 Gy at 2.0 Gy / fraction to the 
PTV-PROST D95%. At first, all datasets were computed with XiO 
superposition (SP). And those plans were exported to Eclipse, 
treatment planning system, and recalculated with anisotropic 
analytical algorithm (AAA) and Acuros XB (AXB) dose calculation 
algorithm. All plans were normalized using XiO calculated MU. 
Calculation grid was set to 0.2 cm in all datasets. AXB was dose to 
medium calculation. Maximum dose, minimum dose, mean dose, D2%, 
D50%, D98% and other dosimetric parameters of the targets and organs-
at-risk generated by XiO SP were compared with the other two dose 
algorithms. 
Results: The ratios of mean values of PR minimum dose for SP, AAA 
and AXB were 1.00, 1.00 and 0.93, respectively. The ratios of mean 
values of PR mean dose were 1.00, 1.00, and 0.99 for the SP, AAA, 
and AXB, respectively. The ratios of mean values of PTV-PROST D95% 
dose for SP was 1.00, for AAA 1.01, and for AXB 0.99.The mean values 
of rectum D2% for SP, AAA and AXB were 74.6, 75.8, 75.6 Gy, 
respectively. The mean values of bladder V60% for SP were 19.1%, for 
AAA 20.0, for AXB 19.5. 
Conclusions: Using AXB dose calculation algorithm, implanted fiducial 
marker in target induces a reduction of the dose homogeneity. 
However, the clinical effect is restrictive that the change of the PTV-
PROST D95% is small with an average of around 1%. Material-overwrite 
in prostate is one of the useful methods to improve calculated dose 
homogeneity. 
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Purpose/Objective: To compare Volumetric-Modulated Arc Therapy 
(VMAT) with conventional intensity modulated radiation therapy 
(IMRT) for Carcinoma of Cervix. 
Materials and Methods: Ten patients with carcinoma of Cervix under 
going treatment in our institution were selected for this study. For 
each patient,plans were generated with the planning CT scan, one 
using Step and Shoot IMRT,and another plan using the volumetric-
modulated arc therapy technique, with 2 arcs. The mean PTV volume 
was 787.58 ± 162 cc (range, 541-1028) and that of CTV was 456.10 ± 
